TCL Archive In Brief: NCI’s Cutler Clarifies Policy On Release Of Survey Data, Tape Duplicates Will Be Available At Cost September 6, 1974
TCL Archive Progression-free survival as a primary endpoint for drug approval requires prospective planning, FDA’s Pazdur says. May 7, 2004
TCL Archive NCI To Expand SPORE Grants Program to Increase Translational Research Funding October 22, 1999